首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1461338

醫用大麻市場，按產品類型、按化合物、按應用、按分銷管道、按地區

Medicinal Cannabis Market, By Product Type, By Compound (Tetrahydrocannabinol and Cannabidiol ), By Application, By Distribution Channel, By Geography .

出版日期: 2024年03月08日 | 出版商:

Coherent Market Insights | 英文 171 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫用大麻市場預計2024年為194.4億美元，預計2031年將達到822.7億美元，2024年至2031年年複合成長率（CAGR）為22.9%，預計還會成長。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	194.4億美元
實際資料	2019-2023	預測期	2024-2031
預測期2023/2024-2030/2031年複合成長率	22.90%	2030/2031 年預測值	822.7億美元

2024 年按地區分類的醫用大麻市場佔有率(%)

醫用大麻又稱醫用大麻，是指利用整個、未經加工的大麻植物或其基本萃取物來治療疾病或改善症狀。大麻含有多種精神活性化合物，可以緩解癌症、阿茲海默症、帕金森氏症、癲癇、慢性疼痛等患者的疼痛、噁心、焦慮和其他症狀。美國以及歐洲和拉丁美洲各國等主要市場的醫用大麻日益合法化，預計將在未來幾年推動對大麻藥物和保健產品的需求。此外，積極的臨床試驗研究探索各種大麻素的藥用特性可能會推動全球醫用大麻的採用。

市場動態：

全球醫用大麻市場的推動因素包括各國醫用大麻日益合法化、患有慢性疼痛和其他醫療用途的患者數量不斷增加、公眾對大麻治療作用的認知不斷提高以及對大麻素藥物製劑的需求不斷增加。和開發的進展是一個主要因素。然而，社會接受度、嚴格監管和有限的大麻分銷管道等挑戰仍然是市場快速成長的障礙。在新興經濟體擴大醫用大麻的使用範圍、推出創新的輸送方法、開發具有醫療功效的合成大麻素藥物以及將大麻萃取物融入營養補充和機能性食品中存在機會。

本研究的主要特點

該報告對全球醫用大麻市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球醫用大麻市場的主要企業。
該報告的見解預計將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球醫用大麻市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球醫用大麻市場時所使用的各種策略矩陣來促進決策。

BOL Pharma
最新動態/更新
Tilray
Medreleaf Corporation
Aurora Cannabis Inc.
Canopy Growth Corporation
Insys Therapeutics Inc.
Aphria Inc.
MGC Pharmaceuticals Limited
GW Pharmaceuticals plc.
Medical Marijuana Inc
Enveric Biosciences
Pascal Biosciences
Realize Therapeutics
Celadon Pharmaceuticals Plc.
MAK Scientific LLC
MIRA Pharmaceuticals
Cardiol Therapeutics

第11章盛衰

繁榮與衰落
綜合機會圖

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI40

The medicinal cannabis market is estimated to be valued at USD 19.44 Bn in 2024 and is expected to reach USD 82.27 Bn by 2031, growing at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 19.44 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	22.90%	2030/2031 Value Projection:	US$ 82.27 Bn

Medicinal Cannabis Market Share (%), By Region, 2024

Medicinal cannabis, also known as medical marijuana, refers to using the whole unprocessed marijuana plant or its basic extracts to treat diseases or improve symptoms. It contains several mind-altering chemical compounds that can relieve pain, nausea, anxiety, and other symptoms in patients with conditions including cancer, Alzheimer's, Parkinson's, epilepsy, and chronic pain. The increasing legalization of medicinal cannabis in major markets like the U.S. and various countries in Europe and Latin America is expected to boost the demand for cannabis-based pharmaceutical and wellness products over the coming years. Moreover, active research in clinical trials to explore the medicinal benefits of various cannabinoids is likely to propel the adoption of medicinal cannabis globally.

Market Dynamics:

The global medicinal cannabis market is primarily driven by the rising legalization of cannabis for medical use across countries, growing patient pool for chronic pain, and other medical applications, increasing public awareness about the therapeutic benefits of cannabis, and ongoing research & development for cannabinoid-based pharmaceutical formulations. However, challenges around social acceptance, strict regulations, and limitations on cannabis distribution channels remain barriers to rapid market growth. Opportunities exist in expanding access to medical cannabis in emerging economies, launching innovative delivery methods, developing synthetic cannabinoid drugs with medical advantages, and integrating cannabis extracts into nutraceuticals and functional foods.

Key Features of the Study:

This report provides an in-depth analysis of the global medicinal cannabis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medicinal cannabis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis Inc., Canopy Growth Corporation, Insys Therapeutics Inc., Aphria Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals plc., Medical Marijuana Inc, Enveric Biosciences, Pascal Biosciences, Realize Therapeutics, Celadon Pharmaceuticals Plc., MAK Scientific LLC, MIRA Pharmaceuticals, and Cardiol Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medicinal cannabis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medicinal cannabis market

Market Segmentation

Product Type:
- Flower
- Concentrates
- Edibles
- Topicals & Transdermals
- Others
Compound:
- Tetrahydrocannabinol (THC)
- Cannabidiol (CBD)
Application:
- Cancer
- Arthritis
- Chronic Pain
- Parkinson's Disease
- Epilepsy
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- BOL Pharma
- Tilray
- Medreleaf Corporation
- Aurora Cannabis Inc.
- Canopy Growth Corporation
- Insys Therapeutics Inc.
- Aphria Inc.
- MGC Pharmaceuticals Limited
- GW Pharmaceuticals plc.
- Medical Marijuana Inc
- Enveric Biosciences
- Pascal Biosciences
- Realize Therapeutics
- Celadon Pharmaceuticals Plc.
- MAK Scientific LLC
- MIRA Pharmaceuticals
- Cardiol Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Compound
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis

4. Global Medicinal Cannabis Market, By Product Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Flower, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Concentrates, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Edibles, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Topicals & Transdermals, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Medicinal Cannabis Market, By Compound, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Tetrahydrocannabinol (THC), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cannabidiol (CBD), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Medicinal Cannabis Market, By Application, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Arthritis, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Parkinson's Disease, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Epilepsy, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Medicinal Cannabis Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Medicinal Cannabis Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Compound, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2024 - Global

10. Company Profiles - Global Medicinal Cannabis Market

BOL Pharma*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Tilray
Medreleaf Corporation
Aurora Cannabis Inc.
Canopy Growth Corporation
Insys Therapeutics Inc.
Aphria Inc.
MGC Pharmaceuticals Limited
GW Pharmaceuticals plc.
Medical Marijuana Inc
Enveric Biosciences
Pascal Biosciences
Realize Therapeutics
Celadon Pharmaceuticals Plc.
MAK Scientific LLC
MIRA Pharmaceuticals
Cardiol Therapeutics